Decision Diagnostics Announces Posting and Airing of Its New GenStrip
Commercial Titled "Monolith"
The GenStrip(TM) Was First Shipped in 2013 as an Inexpensive
Alternative for Users of J&J LifeScan OneTouch(R), Ultra(R),
Ultra2(R), and Ultra Mini(R)
LOS ANGELES, CA -- (Marketwired) -- 03/31/14 -- Decision Diagnostics
Corp. (OTCBB: DECN), the exclusive worldwide sales, service and
regulatory processes agent for the Shasta GenStrip(TM), the Green
Glucose Test Strip, specifically designed to work with the Johnson &
Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing
meters, today announced that its Pharma Tech Solutions subsidiary has
completed and will air in many regions in the U.S. its new commercial
video titled "GenStrip: Monolith." The video is available for viewing
The company will publish a media schedule for GenStrip: "Monolith"
just as soon as all previously purchased commercial spots for the
GenStrip "A Patchwork of Life" spots are completed. The new GenStrip
commercial will be played in most metropolitan areas beginning April
5, 2014. Time has also been booked from a nationwide service for the
local hours of 1:00 pm through 6:00 pm. However, the bulk of the
12,500 purchased commercial plays for thirty days beginning April 5,
2014 will be via saturated cable television buys during late at night
hours, a time tested method used for diabetes and over-the-counter
DECN is also a leading provider of prescription and non-prescription
diagnostics, home testing products for the chronically ill and a
premier developer of revolutionary cell phone centric e-health
products and technologies. DECN's GenStrip(TM) product was cleared by
the U.S. FDA in November 2012, and after several successful long
running legal battles with a division of Johnson & Johnson, Genstrip
was finally introduced to the market in late 2013 as a lower cost
(60%) alternative for user/owners of Johnson and Johnson LifeScan
OneTouch(R) Ultra(R), Ultra2(R) and Ultra Mini(R) glucose meters.
This release contains forward-looking
statements about our business or financial condition that reflect our
assumptions and beliefs based on information currently available. We
can give no assurance that the expectations indicated by such
forward-looking statements will be realized. There may be other risks
and circumstances that we are unable to predict. When used in this
release, words such as "believes," "expects," "forecasts," "intends,"
"projects," "plans," "anticipates," "estimates," "will" and similar
expressions are intended to identify forward-looking statements,
although there may be certain statements not accompanied by such
For further information about Shasta GenStrip, please visit the
company's Web Sites: http://www.decisiondiagnostics.com or
http://www.shastagenstrip.com or www.pharmatechdirect.com.
GenStrip(TM) test strips are a product of Pharma Tech Solutions, Inc.
and are not manufactured, distributed, endorsed, or approved by, nor
associated with, LifeScan(R), Inc. a Johnson & Johnson(R) Company,
manufacturers and distributors of the OneTouch(R) Ultra(R) Family of
meters and OneTouch(R) Ultra(R) test strips.
Decision Diagnostics Corp.
Press spacebar to pause and continue. Press esc to stop.